Aprea Therapeutics (APRE) vs Scienture (SCNX)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Aprea Therapeutics is the larger company by market cap ($7.0 million vs $6.3 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Head-to-head
| Metric | APRE | SCNX |
|---|---|---|
| Share price | $0.5582 | $3.86 |
| Market cap | $7.03M | $6.34M |
| 1-day change | -7.74% | -6.54% |
| EPS (TTM) | $-0.95 | $-52.75 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $1.69 | $65.00 |
| 52-week low | $0.548 | $3.23 |
| Distance from 52-week high | -66.97% | -94.06% |
| Average volume | 277.08K | 225.04K |
| Shares outstanding | 12.59M | 1.64M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
APRE vs SCNX FAQ
Which is bigger, Aprea Therapeutics or Scienture?
Aprea Therapeutics (APRE) is larger, with a market capitalization of $7.03M compared with $6.34M for Scienture (SCNX).
Are Aprea Therapeutics and Scienture in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.